Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFUSE: Platelet Transfusions in Sepsis
NCT03090919Phase 2Withdrawn
- Start
- Jan 2017
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of platelets in sepsis, Thrombocytopenia. Planned start Jan 2017; status: withdrawn.
02
Drugs
platelets
03
Conditions
sepsisThrombocytopenia
Beyond the preview
Go deeper on NCT03090919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090919.